• For Supporters

Cancer Research UK thanks Tania Bryer for a decade of fundraising as chair of the National Events Committee

19 April 2022

• Science & Technology

A urine test for bladder cancer: What’s the latest?

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

16 April 2022

• Science & Technology

Detecting multiple cancers with a ‘simple' blood test: Where are we?

A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality? A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality?

14 April 2022

• For Researchers

The new home for your research tools

Cancer Research UK is making it easier for the cancer research community to both contribute and access research tools Cancer Research UK is making it easier for the cancer research community to both contribute and access research tools

11 April 2022

• For Researchers

The award-winning team transforming breast cancer treatment

We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness… We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness…

10 April 2022

• Health & Medicine

Triple negative breast cancer drug given initial ‘no’ for NHS in England

Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer. Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.

8 April 2022

• Health & Medicine

Emergency presentations: what are they, and what do they mean for cancer survival?

A new study from the ICBP has reported international differences in proportions of cancer emergency presentations, and links this to differences in cancer survival. A new study from the ICBP has reported international differences in proportions of cancer emergency presentations, and links this to differences in cancer survival.

7 April 2022

• Science & Technology

Personalised blood test could help predict which lung cancers might return

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

1 April 2022

• For Researchers

Your questions on our research strategy

We answer questions from the research community about our refreshed Research Strategy We answer questions from the research community about our refreshed Research Strategy

29 March 2022

• Health & Medicine

Is there a right way to check your body for cancer? 

There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking. There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking.

29 March 2022